{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:10:25Z","timestamp":1787922625045,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s40290-020-00362-9","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T05:10:28Z","timestamp":1604553028000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Strategies to Reduce Errors Associated with 2-Component Vaccines"],"prefix":"10.1007","volume":"35","author":[{"given":"Farzana","family":"Samad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7674-3976","authenticated-orcid":false,"given":"Diana","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Smetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danial","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"362_CR1","unstructured":"Centers for Disease Control and Prevention. What would happen if we stopped vaccinations? 2017. https:\/\/www.cdc.gov\/vaccines\/vac-gen\/whatifstop.htm. Accessed 16 Jan 2019."},{"key":"362_CR2","unstructured":"ISMP. ISMP National Vaccine Errors Reporting Program 2017 analysis (part I): vaccine errors.continue with little change. ISMP Medicat Saf Alert! Acute Care. 2018;23(12):1\u20135."},{"key":"362_CR3","unstructured":"ISMP. ISMP National Vaccine Errors Reporting Program part II: preparing for immunization activities and campaigns. ISMP Medicat Saf Alert! Acute Care. 2018;23(13):1\u20138."},{"key":"362_CR4","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1016\/j.vaccine.2015.05.006","volume":"33","author":"BF Hibbs","year":"2015","unstructured":"Hibbs BF, Moro PL, Lewis P, Miller ER, Shimabukuro TT. Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000\u20132013. Vaccine. 2015;33:3171\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.006.","journal-title":"Vaccine."},{"issue":"4","key":"362_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/NHH.0000000000000371","volume":"34","author":"A Shastay","year":"2016","unstructured":"Shastay A. Administering just the diluent or one of two vaccine components leaves patients unprotected. Home Healthc Now. 2016;34(4):218\u201320. https:\/\/doi.org\/10.1097\/NHH.0000000000000371.","journal-title":"Home Healthc Now."},{"key":"362_CR6","unstructured":"ISMP. RabAvert needs better packaging. ISMP Medicat Saf Alert! Acute Care. 2013;18(21):1\u20132."},{"key":"362_CR7","unstructured":"Wexler D. Use of vaccines with diluents. 2012. http:\/\/www.immunize.org\/technically-speaking\/20101101.asp. Accessed 27 Nov 2019."},{"issue":"20","key":"362_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.15585\/mmwr.mm6720a4","volume":"67","author":"TT Shimabukuro","year":"2018","unstructured":"Shimabukuro TT, Miller ER, Strikas RA, et al. Vaccine Administration errors involving recombinant zoster vaccine\u2014United States, 2017-2018. Morb Mortal Wkly Rep. 2018;67(20):585\u20136.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"6","key":"362_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.15585\/mmwr.mm6506a4","volume":"65","author":"JR Su","year":"2016","unstructured":"Su JR, Miller ER, Duffy J, Baer BM, Cano MV. Administration error involving a meningococcal conjugate vaccine\u2014United States, March 1, 2010-September 22, 2015. Morb Mortal Wkly Rep. 2016;65(6):161\u20132.","journal-title":"Morb Mortal Wkly Rep"},{"key":"362_CR10","unstructured":"ISMP. ActHIB component of two-vial Pentacel is repeatedly missed. ISMP Medicat Saf Alert! Acute Care. 2011;16(10):1\u20132."},{"key":"362_CR11","unstructured":"ISMP. Confusion abounds! 2-year summary of the ISMP national vaccine errors reporting program (part I). ISMP Medicat Saf Alert! Acute Care. 2014;19(24):1\u20136."},{"key":"362_CR12","unstructured":"ISMP. Vaccine with two components. ISMP Medicat Saf Alert! Acute Care. 2009;14(16):1."},{"key":"362_CR13","unstructured":"National Institute of Allergy and Infectious Diseases. What is a vaccine adjuvant? 2015. https:\/\/www.niaid.nih.gov\/research\/what-vaccine-adjuvant. Accessed 16 Jan 2019."},{"key":"362_CR14","unstructured":"National Institute of Allergy and Infectious Diseases. Vaccine types. 2012. https:\/\/www.niaid.nih.gov\/research\/vaccine-types. Accessed 16 Jan 2019."},{"key":"362_CR15","doi-asserted-by":"publisher","unstructured":"ISMP. ISMP outlines error-prevention strategies for two-component vaccines. Pharm Today. 2018;24(3):45. https:\/\/doi.org\/10.1016\/j.ptdy.2018.02.028.","DOI":"10.1016\/j.ptdy.2018.02.028"},{"issue":"3","key":"362_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.15585\/mmwr.mm6703a6","volume":"67","author":"MM McNeil","year":"2018","unstructured":"McNeil MM, Hibbs BF, Miller ER, Cano MV. Errors in administration of an excess dosage of yellow fever vaccine-United States, 2017. Morb Mortal Wkly Rep. 2018;67(3):109\u201310.","journal-title":"Morb Mortal Wkly Rep"},{"key":"362_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DDDT.S3687","volume":"4","author":"A Nalca","year":"2010","unstructured":"Nalca A, Zumbrun EE. ACAM2000TM: the new smallpox vaccine for United States strategic national stockpile. Drug Des Devel Ther. 2010;4:71\u20139.","journal-title":"Drug Des Devel Ther."},{"issue":"8","key":"362_CR18","first-page":"54510","volume":"8","author":"NM Elden","year":"2016","unstructured":"Elden NM, Ismail A. The importance of medication errors reporting in improving the quality of clinical care services. Glob J Health Sci. 2016;8(8):54510.","journal-title":"Glob J Health Sci."},{"key":"362_CR19","unstructured":"ISMP. Administering just the diluent or one of two vaccine components leaves patients unprotected. ISMP Medicat Saf Alert! Acute Care. 2014;19(10):1\u20134.20."},{"key":"362_CR20","unstructured":"ACTHIB [package insert]. Birdegewater, NJ; Sanofi Pasteur Inc; 1993."},{"key":"362_CR21","unstructured":"HIBERIX [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2009."},{"key":"362_CR22","unstructured":"IMOVAX RABIES [package insert]. Bridegewater, NJ: Sanofi Pasteur Inc; 1980."},{"key":"362_CR23","unstructured":"MENVEO [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2019."},{"key":"362_CR24","unstructured":"PENTACEL [package insert]. Bridegewater, NJ: Sanofi Pasteur Inc; 2008."},{"key":"362_CR25","unstructured":"ROTARIX [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2008."},{"key":"362_CR26","unstructured":"RABAVERT [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 1997."},{"key":"362_CR27","unstructured":"SHINGRIX [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2017."},{"key":"362_CR28","unstructured":"YF-VAX [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 1953."},{"key":"362_CR29","unstructured":"VAXCHORA [package insert]. Redwood City, CA: Paxvax, Inc; 2016."},{"key":"362_CR30","unstructured":"M-M-R II [package insert]. Whitehouse Station, NJ: Merck Sharp & Dohme Corp; 1971."},{"key":"362_CR31","unstructured":"PROQUAD [package insert]. Whitehouse Station, NJ: Merck Sharp & Dohme Corp; 2005."},{"key":"362_CR32","unstructured":"VARIVAX [package insert]. Whitehouse Station, NJ: Merck Sharp & Dohme Corp; 1995."},{"key":"362_CR33","unstructured":"ZOSTAVAX [package insert]. Whitehouse Station, NJ: Merck Sharp & Dohme Corp; 2006."},{"key":"362_CR34","unstructured":"Vaccine Innovation Prioritisation Strategy (VIPS): VIPS Phase II executive summary: Dual-chamber delivery devices. 2020. https:\/\/www.gavi.org\/sites\/default\/files\/about\/market-shaping\/Phase-II\/5_VIPS%20Phase%20II_Executive%20Summary_Dual%20Chamber%20Delivery%20Devices.pdf. Accessed 15 Sep 2020."},{"key":"362_CR35","unstructured":"ISMP. Oral vaccine mistakenly given by injection. ISMP Medicat Saf Alert! Acute Care. 2014;19(3):1\u20133."},{"key":"362_CR36","unstructured":"Food and Drug Administration. Safety considerations for container labels and carton labeling design to minimize medication errors. 2013. https:\/\/www.fda.gov\/ucm\/groups\/fdagov-public\/@fdagov-drugs-gen\/documents\/document\/ucm349009.pdf. Accessed 27 Nov 2019."},{"key":"362_CR37","unstructured":"Food and Drug Administration. Safety considerations for product design to minimize medication errors. 2016. https:\/\/www.fda.gov\/ucm\/groups\/fdagov-public\/@fdagov-drugs-gen\/documents\/document\/ucm331810.pdf. Accessed 27 Nov 2019."},{"key":"362_CR38","unstructured":"ElastiTag. https:\/\/www.elastitag.com\/. Accessed 13 Feb 2019."},{"key":"362_CR39","unstructured":"CDC. Vaccine Label Examples. 2020. https:\/\/www.cdc.gov\/vaccines\/hcp\/admin\/storage\/guide\/vaccine-storage-labels.pdf. Accessed 8 Aug 2019. Accessed 11 Sep 2020."},{"key":"362_CR40","unstructured":"CDC. Web-based Training Course. 2020. https:\/\/www.cdc.gov\/vaccines\/ed\/youcalltheshots.html. Accessed 11 Sep 2020."},{"key":"362_CR41","unstructured":"Immunization Action Coalition. Don\u2019t be Guilty of These Preventable Errors in Vaccine Administration! 2019. https:\/\/www.immunize.org\/catg.d\/p3033.pdf. Accessed 11 Sep 2020."},{"issue":"5","key":"362_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385\u201396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003.","journal-title":"Drug Saf"},{"key":"362_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-016-0265-8","author":"I Ribeiro-Vaz","year":"2016","unstructured":"Ribeiro-Vaz I, Silva AM, Costa Santos C, Cruz-Correia R. How to promote adverse drug reaction reports using information systems\u2014a systematic review and meta-analysis. BMC Med Inform Decis Mak. 2016. https:\/\/doi.org\/10.1186\/s12911-016-0265-8.","journal-title":"BMC Med Inform Decis Mak"},{"key":"362_CR44","unstructured":"Vx Labels. Vaccine Information: Menveo. 2016. https:\/\/vxlabels.com\/lib\/vaccines\/vax\/menveo-2\/page\/6\/. Accessed 11 Sep 2020."}],"updated-by":[{"DOI":"10.1007\/s40290-020-00369-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000}}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-020-00362-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40290-020-00362-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-020-00362-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T09:56:32Z","timestamp":1611914192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40290-020-00362-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["362"],"URL":"https:\/\/doi.org\/10.1007\/s40290-020-00362-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40290-020-00369-2","asserted-by":"object"}]},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"5 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of the article, the below sentence in the Report Events and Concerns paragraph was erroneously published.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for this work. The open access fee was paid by the United States Pharmacopoeia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare they have no conflicts or competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the current opinion article. The first draft of the manuscript was written by Farzana Samad, Samantha J. Burton, and Diana Kwan. Material preparation, data collection and analysis were performed by Diana Kwan, Noah Porter, Michael R. Cohen, and Judy Smetzer. Jeanne Tuttle, Danial Baker, and Dennis E. Doherty provided critical review. All authors commented on previous versions of the manuscript and read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}